Zobrazeno 1 - 10
of 580
pro vyhledávání: '"A. Gafita"'
Autor:
Hein, Stefan P., Schultheiss, Manuel, Gafita, Andrei, Zaum, Raphael, Yagubbayli, Farid, Tauber, Robert, Rauscher, Isabel, Eiber, Matthias, Pfeiffer, Franz, Weber, Wolfgang A.
Assessing tumor response to systemic therapies is one of the main applications of PET/CT. Routinely, only a small subset of index lesions out of multiple lesions is analyzed. However, this operator dependent selection may bias the results due to poss
Externí odkaz:
http://arxiv.org/abs/2406.09327
Autor:
John Nikitas, Andrei Gafita, Matthias R. Benz, Loïc Djaïleb, Andrea Farolfi, Masatoshi Hotta, Ida Sonni, Rejah Alano, Matthew Rettig, John Shen, Wesley Armstrong, Tristan Grogan, Sandy Liu, Johannes Czernin, Jeremie Calais
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract For prostate cancer patients who experience biochemical progression during androgen deprivation therapy (ADT), prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) has not been prospectively compa
Externí odkaz:
https://doaj.org/article/2d25a6d37a594d7b82be5f6b5ab994d5
Autor:
Ken Herrmann, Andrei Gafita, Johann S. de Bono, Oliver Sartor, Kim N. Chi, Bernd J. Krause, Kambiz Rahbar, Scott T. Tagawa, Johannes Czernin, Ghassan El-Haddad, Connie C. Wong, Zhaojie Zhang, Celine Wilke, Osvaldo Mirante, Michael J. Morris, Karim Fizazi
Publikováno v:
EClinicalMedicine, Vol 77, Iss , Pp 102862- (2024)
Summary: Background: [177Lu]Lu-PSMA-617 (177Lu-PSMA-617) prolonged life in patients with metastatic castration-resistant prostate cancer (mCRPC) in VISION (NCT03511664). However, distinguishing between patients likely and unlikely to respond remains
Externí odkaz:
https://doaj.org/article/b900010b053c4d47a08e83b23c5b2523
Autor:
Nikitas, John1 (AUTHOR), Gafita, Andrei2 (AUTHOR), Benz, Matthias R.3 (AUTHOR), Djaïleb, Loïc3 (AUTHOR), Farolfi, Andrea4 (AUTHOR), Hotta, Masatoshi3 (AUTHOR), Sonni, Ida3,5,6 (AUTHOR), Alano, Rejah3 (AUTHOR), Rettig, Matthew7,8 (AUTHOR), Shen, John7 (AUTHOR), Armstrong, Wesley3 (AUTHOR), Grogan, Tristan9 (AUTHOR), Liu, Sandy10 (AUTHOR), Czernin, Johannes3 (AUTHOR), Calais, Jeremie3 (AUTHOR) JCalais@mednet.ucla.edu
Publikováno v:
Scientific Reports. 10/17/2024, Vol. 14 Issue 1, p1-8. 8p.
Autor:
Herrmann, Ken, Gafita, Andrei, de Bono, Johann S., Sartor, Oliver, Chi, Kim N., Krause, Bernd J., Rahbar, Kambiz, Tagawa, Scott T., Czernin, Johannes, El-Haddad, Ghassan, Wong, Connie C., Zhang, Zhaojie, Wilke, Celine, Mirante, Osvaldo, Morris, Michael J., Fizazi, Karim
Publikováno v:
In eClinicalMedicine November 2024 77
Publikováno v:
In PET Clinics July 2024 19(3):417-430
Publikováno v:
In PET Clinics July 2024 19(3):363-369
Autor:
Ida Sonni, Andrei Gafita, Lena M. Unterrainer, Rejah M. Alano, Stephanie Lira, John Shen, Alexandra Drakaki, Tristan Grogan, Matthew B. Rettig, Johannes Czernin, Jeremie Calais
Publikováno v:
EJNMMI Research, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract Background PSMA expression is influenced by hormonal status. We evaluated changes in PSA and whole-body 68Ga-PSMA-11 PET/CT (WB-PSMA PET) after initiation of androgen receptor signaling inhibitors (ARSi). Methods Prospectively enrolled patie
Externí odkaz:
https://doaj.org/article/fc9be906f81d4f2fb2a2b86d91fd4eaf
Autor:
Vishnu Murthy, Emmanuel Appiah-Kubi, Kathleen Nguyen, Pan Thin, Masatoshi Hotta, John Shen, Alexandra Drakaki, Matthew Rettig, Andrei Gafita, Jeremie Calais, Ida Sonni
Publikováno v:
European Journal of Hybrid Imaging, Vol 7, Iss 1, Pp 1-13 (2023)
Abstract Purpose To evaluate whether quantitative whole-body (WB) PSMA-PET metrics under long-term androgen deprivation therapy (ADT) and/or androgen receptor signaling inhibitors (ARSi) are associated with PSA progression. Methods Patients who under
Externí odkaz:
https://doaj.org/article/50a32eb3847a4d65845ef2925ba1835b
Autor:
Voter, Andrew F. *, Werner, Rudolf A., Savas, Hatice, Gafita, Andrei *, Ross, Ashley E., Gorin, Michael A., Solnes, Lilja B. *, Pomper, Martin G. *, Rowe, Steven P., Sheikhbahaei, Sara *
Publikováno v:
In Seminars in Nuclear Medicine January 2024 54(1):119-131